Pharming Group (NASDAQ:PHAR) Shares Gap Up to $11.07

Pharming Group (NASDAQ:PHARGet Rating)’s share price gapped up prior to trading on Monday . The stock had previously closed at $11.07, but opened at $12.00. Pharming Group shares last traded at $11.45, with a volume of 1 shares changing hands.

Analysts Set New Price Targets

Separately, TheStreet raised shares of Pharming Group from a “d+” rating to a “c” rating in a report on Monday, August 15th.

Pharming Group Stock Performance

The stock has a market capitalization of $763.78 million, a P/E ratio of 28.54 and a beta of -0.30. The company has a debt-to-equity ratio of 0.60, a quick ratio of 4.68 and a current ratio of 5.40. The company’s fifty day simple moving average is $10.58 and its two-hundred day simple moving average is $9.51.

About Pharming Group

(Get Rating)

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema.

Further Reading

Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.